Trans-2,3-enoyl-CoA reductase-like-related catecholaminergic polymorphic ventricular tachycardia with regular ventricular tachycardia and response to flecainide.
CPVT
TECRL
cardiac arrest
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
23
06
2023
received:
09
01
2023
accepted:
10
07
2023
medline:
18
9
2023
pubmed:
20
7
2023
entrez:
20
7
2023
Statut:
ppublish
Résumé
We describe a unique case of TECRL-CPVT presented with cardiac arrest. Post resuscitation, the patient developed regular ventricular tachycardia featuring a left purkinje system morphology. There was clear suppression of arrhythmia with the addition of flecainide and isolated ventricular ectopy causing secondary T-wave changes. A high index of suspicion was required to eventually make the diagnosis through whole exome sequencing.
Substances chimiques
Flecainide
K94FTS1806
Anti-Arrhythmia Agents
0
Oxidoreductases
EC 1.-
Ryanodine Receptor Calcium Release Channel
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1996-2001Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Pflaumer A, Wilde AAM, Charafeddine F, Davis AM. 50 years of catecholaminergic polymorphic ventricular tachycardia (CPVT)-time to explore the dark side of the moon. Heart Lung Circ. 2020;29(4):520-528.
Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13(8):1077-1109.
Xie L, Hou C, Jiang X, Zhao J, Li Y, Xiao T. A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family. Eur J Med Genet. 2019;62(7):103631.
Devalla HD, Gélinas R, Aburawi EH, et al. TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT. EMBO Mol Med. 2016;8(12):1390-1408.
Bhuiyan ZA, Hamdan MA, Shamsi ETA, et al. A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J Cardiovasc Electrophysiol. 2007;18(10):1060-1066.
Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10(12):1932-1963.
Webster G, Aburawi EH, Chaix MA, et al. Life-threatening arrhythmias with autosomal recessive TECRL variants. EP Europace. 2021;23(5):781-788.
Haïssaguerre M, Duchateau J, Dubois R, et al. Idiopathic ventricular fibrillation. JACC Clin Electrophysiol. 2020;6(6):591-608.
Pérez-Riera AR, Barbosa-Barros R, de Rezende Barbosa MPC, Daminello-Raimundo R, de Lucca AA, de Abreu LC. Catecholaminergic polymorphic ventricular tachycardia, an update. Ann Noninvasive Electrocardiol. 2018;23(4):e12512.
Sung RK, Boyden PA, Scheinman M. Cellular physiology and clinical manifestations of fascicular arrhythmias in normal hearts. JACC Clin Electrophysiol. 2017;3(12):1343-1355.
Durrani SA, Sung R, Scheinman M. Bidirectional ventricular tachycardia due to a mixture of focal fascicular firing and reentry. Cardiac Electrophysiol Clinics. 2016;8(4):753-764.
Kimber SK, Downar E, Harris L, et al. Mechanisms of spontaneous shift of surface electrocardiographic configuration during ventricular tachycardia. JACC. 1992;20(6):1397-1404.
Backx PH. Serving up the ping-pong mechanisms for biventricular ventricular tachycardia. Heart Rhythm. 2011;8(4):606-607.
Walsh R, Adler A, Amin AS, et al. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death. Eur Heart J. 2022;43(15):1500-1510.
Charafeddine F, Assaf N, Ismail A, Bulbul Z. Novel trans-2, 3-enoyl-CoA reductase-like variant associated with catecholaminergic polymorphic ventricular tachycardia type 3. HeartRhythm Case Rep. 2023;9(3):171-177.